ResMed (RMD) PT Raised to $200 at RBC Capital
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $226.74 --0%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Join SI Premium – FREE
RBC Capital analyst Craig Wong-Pan raised the price target on ResMed (NYSE: RMD) to $200.00 (from $187.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Citi raises EquipmentShare price target to $22, keeps Neutral
- WeRide Inc (WRD) PT Lowered to $10.70 at BofA Securities
- Wells Fargo Upgrades FOX Corp. (FOXA) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
